The store will not work correctly when cookies are disabled.
N-(4-iodo-2,5-dimethylphenyl)-2-methyl-3-nitrobenzamide
ID: ALA4099317
PubChem CID: 2211331
Max Phase: Preclinical
Molecular Formula: C16H15IN2O3
Molecular Weight: 410.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(NC(=O)c2cccc([N+](=O)[O-])c2C)c(C)cc1I
Standard InChI: InChI=1S/C16H15IN2O3/c1-9-8-14(10(2)7-13(9)17)18-16(20)12-5-4-6-15(11(12)3)19(21)22/h4-8H,1-3H3,(H,18,20)
Standard InChI Key: KGADPECMURFCNQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
3.9360 -1.8861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9348 -2.7056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6429 -3.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3525 -2.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3497 -1.8825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6411 -1.4772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0609 -3.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0622 -3.9298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7679 -2.7029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4763 -3.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4729 -3.9261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1805 -4.3335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8885 -3.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8846 -3.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1765 -2.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2268 -3.1137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5194 -2.7045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2261 -3.9309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5902 -2.6901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5974 -4.3303 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
6.7646 -4.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6427 -3.9318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 16 1 0
16 17 1 0
16 18 2 0
14 19 1 0
13 20 1 0
11 21 1 0
3 22 1 0
M CHG 2 16 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 410.21 | Molecular Weight (Monoisotopic): 410.0127 | AlogP: 4.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.24 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.47 | CX LogD: 5.47 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.46 | Np Likeness Score: -1.97 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |